Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
The innovative drug sector on the Hong Kong stock market rose in late trading, with CanSino Biologics (09926.HK) and Sino Biopharmaceutical (01530.HK) up more than 6%, WuXi Biologics (02269.HK), Hutchison China MediTech (00013.HK), and Innovent Biologics (01801.HK) rose more than 5%, while WuXi AppTec (02359.HK) gained more than 4%.
The innovative drug sector on the Hong Kong stock market rose in late trading, with CanSino Biologics (09926.HK) and Sino Biopharmaceutical (01530.HK) gaining more than 6%, WuXi Biologics (02269.HK), Hutchison China MediTech (00013.HK), and Innovent Biologics (01801.HK) rose more than 5%, while WuXi AppTec (02359.HK) gained more than 4%.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading


